Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lassmann-Vague

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Diabetes Care|August 1, 1994
Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patientsD Raccah, V Lassmann-Vague, M C Alessi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1996
Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodiesV Lassmann-Vague, P Belicar, C Alessis, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1994
SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administrationV Lassmann-Vague, D Raccah, M Pugeat, et al.
Diabetologia|August 1, 1988
Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of type 1 (insulin-dependent) diabetesB Vialettes, C Mattei-Zevaco, C Badier, et al.
Diabetes Care|September 10, 1999
Silent myocardial ischemia in patients with diabetes: who to screenB Janand-Delenne, B Savin, G Habib, et al.
Diabetes Care|April 1, 1995
Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequencesV Lassmann-Vague, P Belicar, D Raccah, et al.
Diabete & Metabolisme|December 1, 1988
Increased prevalence of neurologic complications among insulin dependent diabetic patients of Algerian originP Vague, O Brunetti, A M Valet, et al.
Diabetes Care|November 5, 1998
Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationshipV Lassmann-Vague, M SanMarco, P J LeJeune, et al.
Diabetes Care|June 18, 1999
Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birthP Belicar, N Jeandidier, E Renard, et al.
Diabetes Care|July 1, 1993
Acute insulin response to glucose and glucagon in subjects at risk of developing type I diabetesB Vialettes, C Zevaco-Mattei, X Thirion, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Diabetes Care|August 1, 1994
Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patientsD Raccah, V Lassmann-Vague, M C Alessi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1996
Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodiesV Lassmann-Vague, P Belicar, C Alessis, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1994
SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administrationV Lassmann-Vague, D Raccah, M Pugeat, et al.
Diabetologia|August 1, 1988
Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of type 1 (insulin-dependent) diabetesB Vialettes, C Mattei-Zevaco, C Badier, et al.
Diabetes Care|September 10, 1999
Silent myocardial ischemia in patients with diabetes: who to screenB Janand-Delenne, B Savin, G Habib, et al.
Diabetes Care|April 1, 1995
Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequencesV Lassmann-Vague, P Belicar, D Raccah, et al.
Diabete & Metabolisme|December 1, 1988
Increased prevalence of neurologic complications among insulin dependent diabetic patients of Algerian originP Vague, O Brunetti, A M Valet, et al.
Diabetes Care|November 5, 1998
Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationshipV Lassmann-Vague, M SanMarco, P J LeJeune, et al.
Diabetes Care|June 18, 1999
Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birthP Belicar, N Jeandidier, E Renard, et al.
Diabetes Care|July 1, 1993
Acute insulin response to glucose and glucagon in subjects at risk of developing type I diabetesB Vialettes, C Zevaco-Mattei, X Thirion, et al.
Pageof 5